In patients with type 2 diabetes, GPR26 is down-regulated due to chronic hyperglycemic conditions and accompanied by increased production of reactive oxygen species, pro-inflammatory monocyte activation and adhesion to endothelial cells (Kichi et al., 2022). The gene discussed is GPR26; the disease is type 2 diabetes mellitus.